|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Breast Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| denileukin diftitox | |||||
| flow cytometry | |||||
| immunoenzyme technique | |||||
| laboratory biomarker analysis | |||||
| protein expression analysis | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Interleukin-2 | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Antineoplastic Agents | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Fred Hutchinson Cancer Research Center | |||||
| National Cancer Institute (NCI) | |||||